Visit the otherwebsites
Visit the IBA websites

Protect, Enhance and Save Lives

Shaping the future
of cancer treatment

IBA develops, manufactures and supports medical devices and software solutions for cancer treatment by proton beam therapy, for cancer diagnosis and for patient quality assurance (Dosimetry). In addition, the company partners with healthcare leaders to provide cancer clinics and academic health centers with a fully-integrated approach of the patient flow.

News

What is
proton
therapy ?

August 28th, 2014
14.00 CET

IBA First Half
2014 Results
Conference Call

IBA First Half
2014 Results
Conference Call

IBA will host a webcast conference call and Q&A session at 14.00 CET on Thursday, August 28 2014. Olivier Legrain, Chief Executive Officer, and Jean-Marc Bothy, Chief Financial Officer, will host the call, which will be conducted in English. 

The conference call will be webcast live and may be accessed at:

http://arkadinemea-events.adobeconnect.com/iba/

If you would like to participate in the Q&A, dial (PIN code 69403589#):

Belgium: +32 (0)2 404 03 05 LU: +352 2786 01 66 UK: +44 (0)20 7750 99 26 US: +1 914 885 07 79 NL: +31 (0)20 713 34 88 FR: +33 (0)1 72 04 00 33

Shortly after the call, the presentation will be available on the Company's website.

august 28th, 2014
14.00 CET

Job Finder

Calendar

Back to top